Joensuu, G. et al. 2012. A phase II trial of gefitinib in patients with rising PSA following radical prostatectomy or radiotherapy. Acta Oncologica. 51, 1 (Jan. 2012), 130–133. DOI:https://doi.org/10.3109/0284186X.2011.617387.